Latest news
Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing
A new HCPLive expert discussion highlights growing attention to hypercortisolism as a possible contributor to resistant hypertension and difficult-to-control cardiometabolic disease. Emerging data from MOMENTUM and CATALYST suggest cortisol excess may be more common in these high-risk groups than previously assumed. The policy challenge is not simply whether to screen more patients. It is who…
A Year of Measles in Utah Is What Lost Protection Looks Like
Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?
MASH, a serious fatty liver disease, is becoming a cardiometabolic condition
Cervical Cancer Cannot Be Left Waiting at the Edge of the ADC Era
Do Not Turn Cancer Trials Into Political Collateral
A Seizure Diagnosis Should Not Automatically End a Career
IPM Brief – Issue 6 | Who Gets to Decide?
Mental Health Patients Need Care, Not Surveillance
Bird Flu Reached Australia. Now Preparedness Has to Deliver.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.